ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 230 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $279 | -87.7% | 51,200 | -84.9% | 0.00% | -100.0% |
| Q2 2023 | $2,271 | -34.7% | 338,500 | -14.1% | 0.00% | -40.0% |
| Q1 2023 | $3,479 | +9.5% | 394,000 | -5.2% | 0.01% | +25.0% |
| Q4 2022 | $3,177 | -99.9% | 415,800 | -9.2% | 0.00% | -20.0% |
| Q3 2022 | $3,260,000 | -17.2% | 457,800 | -5.9% | 0.01% | 0.0% |
| Q2 2022 | $3,936,000 | -37.8% | 486,500 | +6.8% | 0.01% | -28.6% |
| Q1 2022 | $6,324,000 | -2.0% | 455,600 | +184.4% | 0.01% | -12.5% |
| Q1 2021 | $6,450,000 | – | 160,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
| Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
| Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
| Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
| TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
| Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
| Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
| Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
| Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |